Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Should You Buy Beaten Down Cannabis Stocks & ETFs Now?

Published 12/02/2021, 06:01 AM
Updated 07/09/2023, 06:31 AM

  • (1:00) - Inflation Worries: Understanding The Recent Market Action
  • (6:50) - Where Should Investors Put Their Cash To Work?
  • (15:00) - Can We Expect Federal Legalization For Marijuana Anytime Soon?
  • (25:45) - Germany Set To Legalize Marijuana: What Impact Will This Have On The Market?
  • (33:30) - Amplify Seymour Cannabis ETF: CNBS
  • (39:10) - Will We Continue To See More Consolidation Within The Market?
  • Podcast@Zacks.com

In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, about broader markets, cannabis investing and the Amplify Seymour Cannabis ETF CNBS.

Stocks have been on a roller coaster ride since Friday mainly on concerns related to the new variant of the coronavirus and faster taper timeline. Where should investors put their cash to work?

Cannabis stocks & ETFs are down this year, despite favorable policy outlook and improving industry fundamentals. Investors were earlier hopeful for a more rapid path to full federal legalization with the Democratic majority in both chambers of Congress.

These stocks had rallied briefly last month after reports of a Republican-led legislation proposal that aimed to legalize marijuana at the federal level but gave up their gains after investors realized that prospects of passage are rather low as of now. Tim believes that investors should be paying attention to the SAFE Banking Act that is more important for the industry.

Cannabis remains illegal in most countries around the world. The new government in Germany appears to be in favor of legalizing marijuana for recreational use, and it could become the first major European country to do so.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bloomberg News recently reported that Monster Beverage MNST is interested in a tie-up with Constellation Brands STZ, which has a stake of almost 40% in Canopy Growth (NASDAQ:CGC).

We have seen a lot of consolidation in the industry lately and Tim expects the trend to continue into 2022. What does all this mean for this fast-growing industry?

CNBS now has exposure to Multi-State Operators (MSOs) via swaps. Top holdings in the actively managed ETF also include Canopy Growth CGC and Village Farms VFF.

Tune in to the podcast to learn more.

Make sure to be on the lookout for the next edition of ETF Spotlight and also make sure to subscribe! If you have any comments or questions, please email podcast@zacks.com.


Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Get it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Constellation Brands Inc (NYSE:STZ): Free Stock Analysis Report

Monster Beverage Corporation (NASDAQ:MNST): Free Stock Analysis Report

Canopy Growth Corporation (CGC): Free Stock Analysis Report

Village Farms International, Inc. (NASDAQ:VFF): Free Stock Analysis Report

Amplify Seymour Cannabis ETF (CNBS): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.